Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
出版年份 2021 全文链接
标题
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
作者
关键词
-
出版物
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 78, Issue 5, Pages 421-433
出版商
Elsevier BV
发表日期
2021-07-27
DOI
10.1016/j.jacc.2021.04.102
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
- (2020) Vera A. Bittner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome
- (2020) Gregory G. Schwartz et al. CIRCULATION
- The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
- (2020) Nicholas A. Marston et al. CIRCULATION
- Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis
- (2020) Patrick M. Moriarty et al. Current Atherosclerosis Reports
- Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
- (2020) Michael Szarek et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among Seven Ethnic Groups
- (2019) Guillaume Paré et al. CIRCULATION
- Elevated Lipoprotein(a) and Risk of Ischemic Stroke
- (2019) Anne Langsted et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
- (2019) Hubert Scharnagl et al. ATHEROSCLEROSIS
- Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
- (2019) Daniel F. Gudbjartsson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of Lipoprotein(a) Molar Concentrations and Mass According to Lipoprotein(a) Thresholds and Apolipoprotein(a) Isoform Size
- (2018) Sotirios Tsimikas et al. Journal of Clinical Lipidology
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- (2018) Stephen Burgess et al. JAMA Cardiology
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium
- (2017) Christoph Waldeyer et al. EUROPEAN HEART JOURNAL
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin
- (2017) Robert P. Giugliano et al. JAMA Cardiology
- LPA Gene, Ethnicity, and Cardiovascular EventsClinical Perspective
- (2016) Sang-Rok Lee et al. CIRCULATION
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
- (2014) Gregory G. Schwartz et al. AMERICAN HEART JOURNAL
- Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts
- (2014) A. Laschkolnig et al. CARDIOVASCULAR RESEARCH
- Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease
- (2012) Deepti Gurdasani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein(a)-cholesterol: A significant component of serum cholesterol
- (2011) Kiyoko Kinpara et al. CLINICA CHIMICA ACTA
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started